Clinical Trial: Autologous Blood Patch for Primary Spontaneous Pneumothorax

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: Utilization of Prophylactic Autologous Blood Patch Pleurodesis in the Treatment of Primary Spontaneous Pneumothorax

Brief Summary: The purpose of this study is to show that treatment with prophylactic autologous blood patch (ABP) after management of primary spontaneous pneumothorax (PSP) is feasible, reduces the incidence of prolonged air leaks, and reduces hospital length of stay.
An ABP is a medical procedure that uses one's own blood in order to close one or many holes identified in the lungs.
The blood modulates the pressure of the lungs and forms a clot, sealing the leak.
Primary spontaneous pneumothorax is an abnormal collection of air in the pleural space between the lung and the chest wall.